APOL1 and kidney disorder: Of note, interferon type I produced in this setting inhibits infection of other monocytes by DENV through progressive activation of the JAK/STAT pathway.S11,S12 In this scenario, viral recognition and immunologic response to DENV activate common pathways to APOL1-mediated kidney diseases.